297 related articles for article (PubMed ID: 30785085)
1. Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer's disease.
Chen S; Chen ST; Sun Y; Xu Z; Wang Y; Yao SY; Yao WB; Gao XD
Redox Biol; 2019 Apr; 22():101133. PubMed ID: 30785085
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the Astrocyte-Neuron Lactate Shuttle System contributes to Neuroprotective action of Fibroblast Growth Factor 21.
Sun Y; Wang Y; Chen ST; Chen YJ; Shen J; Yao WB; Gao XD; Chen S
Theranostics; 2020; 10(18):8430-8445. PubMed ID: 32724479
[TBL] [Abstract][Full Text] [Related]
3. FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stress.
Kang K; Xu P; Wang M; Chunyu J; Sun X; Ren G; Xiao W; Li D
Biomed Pharmacother; 2020 Sep; 129():110439. PubMed ID: 32768941
[TBL] [Abstract][Full Text] [Related]
4. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
5. Protective Effects of Fibroblast Growth Factor 21 Against Amyloid-Beta
Amiri M; Braidy N; Aminzadeh M
Neurotox Res; 2018 Oct; 34(3):574-583. PubMed ID: 29869772
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factors as neuroprotective agent in Alzheimer's disease.
Ashok BS; Ajith TA; Sivanesan S
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):327-334. PubMed ID: 28004401
[TBL] [Abstract][Full Text] [Related]
7. Okadaic Acid and Hypoxia Induced Dementia Model of Alzheimer's Type in Rats.
Kaushal A; Wani WY; Bal A; Gill KD; Kaur J
Neurotox Res; 2019 Apr; 35(3):621-634. PubMed ID: 30729451
[TBL] [Abstract][Full Text] [Related]
8. Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments.
Mahaman YAR; Huang F; Wu M; Wang Y; Wei Z; Bao J; Salissou MTM; Ke D; Wang Q; Liu R; Wang JZ; Zhang B; Chen D; Wang X
J Alzheimers Dis; 2018; 63(3):1141-1159. PubMed ID: 29710724
[TBL] [Abstract][Full Text] [Related]
9. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
10. Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer's Disease.
Ali T; Kim T; Rehman SU; Khan MS; Amin FU; Khan M; Ikram M; Kim MO
Mol Neurobiol; 2018 Jul; 55(7):6076-6093. PubMed ID: 29170981
[TBL] [Abstract][Full Text] [Related]
11. Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease.
Kim J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805772
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease.
Olajide OJ; Suvanto ME; Chapman CA
Biol Open; 2021 Jan; 10(1):. PubMed ID: 33495355
[TBL] [Abstract][Full Text] [Related]
13. Focus on Alzheimer's Disease: The Role of Fibroblast Growth Factor 21 and Autophagy.
Yang L; Nao J
Neuroscience; 2023 Feb; 511():13-28. PubMed ID: 36372296
[TBL] [Abstract][Full Text] [Related]
14. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
15. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease.
Wang X; Hu X; Yang Y; Takata T; Sakurai T
Exp Neurol; 2015 Sep; 271():145-54. PubMed ID: 26057947
[TBL] [Abstract][Full Text] [Related]
16. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
17. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
18. Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.
Gugliandolo A; Bramanti P; Mazzon E
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168797
[TBL] [Abstract][Full Text] [Related]
19. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
20. The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease.
Lee S; Bang SM; Hong YK; Lee JH; Jeong H; Park SH; Liu QF; Lee IS; Cho KS
Dis Model Mech; 2016 Mar; 9(3):295-306. PubMed ID: 26659252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
